Navigation Links
District nursing homes win high marks for quality, but antipsychotic prescribing remains problematic
Date:10/19/2013

WASHINGTON, DC (October 17, 2013)The District of Columbia Department of Health (DOH) has released a study by the George Washington University School of Public Health and Health Services (SPHHS) investigating prescribing of antipsychotics to District seniors. The study combines pharmaceutical marketing data collected by the District with publicly available data on nursing home quality and Medicare drug claims.

"The good news is that nursing homes in the District of Columbia generally are not prescribing antipsychotic medication at rates higher than the rest of the country," says Susan F. Wood, PhD, lead researcher and an associate professor of health policy and of environmental and occupational health at SPHHS. "However, there are still concerns that District providers are too quick to prescribe these drugs to District seniors and Medicaid beneficiaries."

Antipsychotics are one of the top-selling drug classes, despite widely reported side effects that include weight gain and sedation. Elderly patients suffering from dementia or agitation may be dosed with antipsychotics for their sedative effects, an off-label use that raises ethical questions. Use of antipsychotics puts seniors at increased risk of serious adverse events, including cognitive decline, hip fractures, and death.

"Senior citizens living in the District of Columbia are the city's most vulnerable population," said Dr. Joxel Garcia, Director, DC Department of Health. "The Department of Health will continue to invest in educating physicians on effective use of antipsychotic medications to provide the better health outcomes for all District residents."

The report fulfills the requirement of a 2004 law in the District of Columbia that requires pharmaceutical companies to file annual reports describing their prescription-drug marketing activities in the District. The AccessRx Act also requires analysis of these reports to determine how pharmaceutical marketing may affect healthcare services in the District.

SPHHS researchers searched District of Columbia marketing data for reports of drug-company gifts made in 2007 - 2011 to physicians who currently serve as nursing home medical directors. The search was done to see if pharmaceutical companies were targeting marketing efforts at the medical directors of nursing homes. The report found that nine of the district's 19 nursing home medical directors received no gifts from pharmaceutical companies between 2007 and 2011. Three received cash or checks for speaking or consulting, which totaled $34,639 over five years. Only four received gifts totaling over $1,000 in at least one of the years studied; six received gifts, mostly food or books, totaling $100 to $800 in at least one year.

The study also examined nursing home quality ratings and rates of antipsychotic prescriptions across eight wards in the district, using ratings from the Nursing Home Compare website run by the Centers for Medicare and Medicaid Services (CMS). Thirteen of the District's 19 nursing homes received above-average ratings (four or five stars) for overall quality. The two nursing homes with the lowest ratings (two stars, or "below average") are both located in Ward 7.

Nursing Home Compare also reports the percentage of short-stay nursing home patients receiving new antipsychotic prescriptions and the percentage of long-stay patients receiving antipsychotic medications. In the District, seven out of 18 nursing homes have above‐average prescribing rates for short‐stay patients, and six out of 19 have above‐average rates of long‐stay patients taking antipsychotics. (Average US rates are 2.7 percent for short-stay patients and 22.4 percent for long-stay patients.)

Researchers also examined data on prescriptions of antipsychotics for Medicare Part D patients, the majority of whom are seniors. The SPHHS report compiles information on 67 District providers who wrote antipsychotic prescriptions for large numbers of Part D patients. Nearly one-third (22 of 67) of these prescribed at least one antipsychotic to 70 percent or more of their Part D patients.

"Many doctors in the District write significant numbers of prescriptions of antipsychotic medication to Medicare patients. This provides a window into prescribing practices here," says Adriane Fugh-Berman, MD, a co-author of the report and an associate professor of pharmacology and physiology at Georgetown University Medical Center.

"As we noted in an earlier report for the Department of Health, the District has a very high percentage of Medicaid beneficiaries receiving antipsychotic medications," Wood says. Data released by CMS just after this report was written indicate that nearly 11 percent of the District's Medicaid beneficiaries filled antipsychotic prescriptions in 2009. "High rates of prescribing antipsychotics, whether to children or elders, raises concerns about the quality of care provided to low-income District residents and the role of pharmaceutical marketing in prescribing practices."

The study can be found on the D.C. Department of Health Website by clicking here.


'/>"/>

Contact: Kathy Fackelmann
kfackelmann@gwu.edu
202-994-8354
George Washington University School of Public Health and Health Services
Source:Eurekalert

Related medicine news :

1. Pelvic Mesh Manufacturers Allegedly in Settlement Talks as Patients’ Attorneys in Multidistrict Litigations Seek Creation of a Settlement Committee, Notes Parker Waichman
2. San Francisco's SOMA (South of Market) District Apartment Rentals At 99% Capacity, Announces 1188 Mission at Trinity Place.
3. Mirena Lawsuit Update: Bernstein Liebhard LLP Reports on Growing Number of Mirena IUD Lawsuits Pending in Federal Multidistrict Litigation
4. DePuy Orthopaedics Inc.’s Multidistrict Litigation Update: First Bellwether Trial to Commence Within 90 Days, Parker Waichman LLP Reports
5. Biomet Hip Replacement News: Federal Multidistrict Litigation for Biomet Hip Lawsuits to Hold Status Conference, Bernstein Liebhard LLP Reports
6. Transvaginal Mesh Multidistrict Litigation Update: Judge Makes Pretrial Ruling on Document Production, Reports Parker Waichman LLP
7. Judge Orders Postponement of First Bellwether Trial in DePuy Orthopaedics Inc.’s Multidistrict Litigation, Pushing It to Sept. 24, Parker Waichman LLP Reports
8. Pradaxa Bleeding Lawyers at Wright & Schulte LLC Note Growing Number of Filings in Federal Multidistrict Litigation Established for Pradaxa Lawsuits
9. Dr. Christine Fialka-Eshenko Elected to Legacy Project Chair of Edmonton and District Dental Society
10. C8 Lawsuit Lawyers at Wright & Schulte LLC Applaud Scheduling of First Trials in Multidistrict Litigation Established for Federal DuPont C8 Lawsuits
11. Dr. Daniel Rose, Medical Director for Healdsburg District Hospital’s Wound Care Program Anticipates Growth and Technology for the Innovative North Bay Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ... February 19, 2017 , ... ProBrand Glitch is a set of 30 glitch distortion logo reveals ... easily reveal any logo with a glitch reveal in just a few clicks of a ... and animation of each preset. Use these presets to add a uniquely animated logo to ...
(Date:2/18/2017)... ... ... Butler Mobility invited Ken Matthews to visit its manufacturing facility and showroom ... impressed with the safety and reliability of the Stannah Stairlift as well as with ... endorsement by Ken Matthews can be heard on News Radio WHP 580 weekdays from ...
(Date:2/17/2017)... ... February 17, 2017 , ... Smiles by Seese is a comprehensive family ... Brian Seese leads the practice as a skilled and highly credentialed dentist who is ... Seese serves patients of all ages with excellence in general, restorative, and cosmetic ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... , **An FDAnews Webinar**, Feb. 22, 2017 — 1:30 p.m. – 2:30 ... questions manufacturers should be asking before selecting an FDA approval pathway? , ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program will serve more than ... the U.S. Soccer Foundation announced today that they have awarded nine grants to ... the Foundation’s soccer mentoring program, teaches kids the fundamentals of soccer while striving ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... 20, 2017  Today from HIMSS17, Ambra Health ... suite, announced the launch of  Ambra for Developers ... Built around modern, RESTful web-services, this is the first ... With these new APIs, IT departments at health ... data into other applications such as population health or ...
(Date:2/20/2017)... Feb 20, 2017 Research and Markets ... Global Market -Forecast to 2022" report to their offering. ... ... in aging population, rising adoption of tension free repair procedures ... growth of hernia repair devices global market. However, Inconsistent reimbursement ...
(Date:2/20/2017)... Feb. 20, 2017  There has been a paradigm ... (NCDs) across sub-Saharan Africa, which in turn is driving ... of more Western lifestyle diseases such as cardiovascular disease ... infectious and parasitic illness, will present the pharmaceutical industry ... opportunity of $40.8 billion in 2019. "An ...
Breaking Medicine Technology: